According to the Government Dashboard to the 14th July, London has the lowest uptake of vaccination in the country and also has the lowest number of COVID 'cases' - and the lowest death rate.
Rebecca Cafe reports for the BBC that more than a third of Londoners remain unvaccinated. Furthermore, 55% of those vaccinated have not had the second dose (3.9M have had second dose out of 5.5M).
Capital COVID rates low
The uptake for all of England is 88% vaccinated and 68% having had the second dose. So, does this mean that London also has the highest rate of infection? The answer is "no". London has one of the lowest rates of Covid-19 'cases', with 298 per 100,000, in comparison to the UK rate of 376.1 per 100,000.
That's so-called "cases". But what about deaths? London also has one of the lowest death rates, this must raise further questions over the actual risk / benefit value of the vaccine.
Summary of the data (courtesy of Rebecca Cafe):
The report highlights the following status:
- 46% of Londoners aged 18-24 have had the first dose, compared with 57.4% across England.
- The South West has the highest percentage of 18-24 year old's vaccinated, at 65%.
- Across London boroughs, Bexley, Bromley, Richmond and Sutton have the highest percentage of residents who have had the first dose.
- Kensington and Chelsea, Newham and Westminster have the lowest percentage of first doses administered.
- London has one of the lowest death rates, with 175 per 100,000 people. The North West has the highest with 248.1 per 100,000.
In response the London Mayor is turning up the volume and setting up all sorts of new vaccination centres. However, there does appear to be increasing concern over COVID vaccine safety, and worries that these new experimental genetic treatments are being rushed out without the usual and necessary informed consent.
Questioning need for vaccination
Doctors for Covid Ethics have today sent a letter to thousands of doctors across Europe.
Summarising four recent scientific findings critical to the COVID-19 vaccination program. They explain the findings as they relate to the biology of COVID-19 vaccines, including interactions with the immune system.They say, ".. these new pieces of evidence force all physicians administering COVID-19 vaccines to re-evaluate the merits of COVID-19 vaccination, in the interests of their own ethical standing, and their patients’ safety and health".
re-evaluate the merits of COVID-19 vaccination
The doctors summarise the recent studies as follows:
Rapid and efficient memory-type immune responses occur reliably in virtually all unvaccinated individuals who are exposed to SARS-CoV-2. The effectiveness of further boosting the immune response through vaccination is therefore highly doubtful. Vaccination may instead aggravate disease through antibody-dependent enhancement (ADE).
Antibody-dependent enhancement (ADE) describes situations where the production of antibodies actually accelerates the disease. In general, virus-specific antibodies are considered antiviral and play an important role in the control of virus infections in a number of ways. However, in some instances, the presence of specific antibodies can be beneficial to the virus.
For some viruses, ADE of infection has become a great concern to disease control by vaccination.
Placing the need for vaccination in context of lack of disease severity
a mild-moderate disease
It is sometimes necessary to go back to basics and remind ourselves of the nature of this disease, what it's impact will be and how we are likely to cope in practice. In order to do so, it is necessary to place the need for vaccination within the context of real medical implications. The most reliable source of information should be the Chief Medical Officer himself. It is worth getting a quick reminder of what Professor Chris Whitty informed us about the nature of the illness in May last year. He said, "Over the whole epidemic, even if there is no vaccine, a high proportion will not get it. Of those who do a significant proportion (exact number not yet clear) will have no symptoms at all. Of those who do have symptoms the great majority will only have a mild to moderate disease". He said that many people will get it without even realising it. This might explain why it would appear that there are high levels of natural immunity.
Why are double-shot patients getting sick?
It is against this back-drop that the risk / benefit of taking an experimental gene therapy should be assessed, as well as taking into consideration the efficacy of the treatment. NB with the reported numbers of so-called 'double shot' vaccinated people becoming ill including the BBC's Andrew Marr, it would also appear that the effectiveness is not as great as we would have wanted. However, we are now being told that if we do get sick, we will likely be less sick. Nonetheless, some hospitals are reporting very high levels of patient hospitalisations among those who have received the two shots, including yesterday's report (25th July 2021) from New South Wales in Australia. "141 people are in hospital, 43 are in intensive care and 18 require ventilation. All but one are vaccinated. One person just received one shot of vaccine".
Following this report the main media outlets have largely focussed on the fact that a woman in her late thirties has died and that the disease is affecting all age groups. No one seems to be asking why all the patients (bar one who only had one shot) are getting hospitalised despite having previously received the 'two shots'. However, you do have to hang on to the end of the press conference and pay attention in order to get the details.